Ables Iannone Moore & Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.04M Sell
11,467
-446
-4% -$118K 1.57% 14
2026
Q2
$3.03M Buy
11,913
+458
+4% +$107K 1.61% 15
2026
Q1
$2.8M Sell
11,455
-679
-6% -$158K 1.67% 14
2025
Q4
$2.51M Sell
12,134
-375
-3% -$74.2K 1.38% 17
2025
Q3
$2.32M Sell
12,509
-1,548
-11% -$265K 1.33% 17
2025
Q2
$2.15M Sell
14,057
-1,424
-9% -$219K 1.34% 17
2025
Q1
$2.57M Sell
15,481
-366
-2% -$57.3K 1.75% 15
2024
Q4
$2.29M Sell
15,847
-107
-0.7% -$16.6K 1.41% 16
2024
Q3
$2.59M Sell
15,954
-123
-0.8% -$19.6K 1.67% 15
2024
Q2
$2.35M Buy
16,077
+1,711
+12% +$254K 1.55% 15
2024
Q1
$2.27M Sell
14,366
-308
-2% -$49K 1.62% 15
2023
Q4
$2.3M Buy
+14,674
New +$2.25M 1.75% 16

Other funds holding JNJ

Ables Iannone Moore & Associates's JNJ Position: Q3 2026 in Review

Ables Iannone Moore & Associates reduced its Johnson & Johnson (JNJ) stake by 3.7% in Q3 2026, selling an estimated $118K and leaving 11,467 shares worth $3.04M. The position accounts for 1.57% of the portfolio, ranked #14.

Ables Iannone Moore & Associates first reported a position in JNJ in Q4 2023 and has held it in 12 quarters since. 3,177 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Ables Iannone Moore & Associates held 11,467 shares of Johnson & Johnson worth $3.04M as of Q3 2026.
  • Ables Iannone Moore & Associates sold 446 Johnson & Johnson shares in Q3 2026, an estimated $118K.
  • Johnson & Johnson made up 1.57% of Ables Iannone Moore & Associates's portfolio in Q3 2026, its #14 holding.
  • Ables Iannone Moore & Associates first reported a position in Johnson & Johnson in Q4 2023 and has held it in 12 quarters since.
  • 3,177 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Ables Iannone Moore & Associates's 13F filing for Q3 2026, filed 6 Oct 2026.